Volume 30 Issue 5
Sep.  2014
Turn off MathJax
Article Contents
WEI Yu. Han Shuren's Clinical Experience of Treating Pulmonary Interstitial Fibrosis with Buyang Huanwu Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(5): 486-488.
Citation: WEI Yu. Han Shuren's Clinical Experience of Treating Pulmonary Interstitial Fibrosis with Buyang Huanwu Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(5): 486-488.

Han Shuren's Clinical Experience of Treating Pulmonary Interstitial Fibrosis with Buyang Huanwu Decoction

  • Received Date: 2014-06-13
  • Rev Recd Date: 2014-08-18
  • Publish Date: 2014-09-10
  • This paper is to introduce Han Shuren's clinical experience of treating pulmonary interstitial fibrosis with Buyang Huanwu Decoction. Han believes the pathogenesis of this disease is the qi and blood deficiency, especially in lung and kidney and he adopts nourishing qi and tonifying kidney as well as activating blood circulation to remove blood stasis as his main treatment principle. He also modifies Buyang Huanwu Decoction according to different situations of the patients with different ages and disease courses in clinic.

     

  • loading
  • [1]
    朱元珏.慢性肺间质病[J].现代呼吸病学,1996, 8(1):714-724.
    [2]
    Zhu YJ. Chronic interstitial lung disease[J]. Mod Respirol, 1996, 8(1): 714-724.
    [3]
    蔡后荣.2011年特发性肺间质纤维化诊断和治疗循证新指南解读[J].中国呼吸与危重监护杂志,2011(10):313-316.
    [4]
    Fu NY. Understanding to guidelines for diopathic pulmonary fibrosis: diagnosis and treatment of 2011[J]. Chin J Respir Crit Care Med, 2011(10): 313-316.
    [5]
    黄帝内经[M].北京:人民卫生出版社,2012:84.
    [6]
    The Yellow Emperor's Inner Classic[M].Beijing:People's medical publishing house, 2012:84.
    [7]
    张仲景.金匮要略[M].北京:学苑出版社,2012:39.
    [8]
    Zhang ZJ.Jinkui Yaolve [M].Beijing: Academy press, 2012:39.
    [9]
    程文囿.医述[M].合肥:安徽人民出版社,1990:681.
    [10]
    Cheng WY. Account of medicine[M]. Hefei: Anhui people's publishing house,1990:681.
    [11]
    陈士铎.辨证录[M].北京:人民卫生出版社,1989:91.
    [12]
    Chen SD. Differentiation of symptoms and signs[M]. Beijing:People's medical publishing house, 1989:91.
    [13]
    张平,李杰平,于小华,等.黄芪甲甙对实验性肺纤维化大鼠Cathepsin B表达的影响[J].现代生物医学进展,2007, 7(6):860-862.
    [14]
    Zhang P, Li JP, Yu XH, et al. Effect of astragalaside on cathepsin B expression in the lung of rats with experimental pulmonary fibrosis[J]. Progr Mod Biomed, 2007, 7(6): 860-862.
    [15]
    江振国.川芎嗪注射液治疗肺间质纤维化临床观察[J].中国中医药信息杂志,2013, 20(9):78-79.
    [16]
    Jiang ZG. Clinical observation of Ligustrazine Injection in the treatment of pulmonary interstitial fibrosis[J]. Chin J Inform Tradit Chin Med, 2013, 20(9): 78-79.
    [17]
    范京国,周东民.补阳还五汤临床应用研究进展[J].甘肃中医,2002, 15(2):81-82.
    [18]
    Fan JG, Zhou DM. Study progress in clinical application of Buyang Huanwu Decoction[J]. Gansu J Tradit Chin Med , 2002, 15(2): 81-82.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (5267) PDF downloads(3272) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return